The liquid handling system market will reach a value of USD 6,521 million by 2030, powering at a compound annual growth rate of 4.20% by the end of this decade. The growth of the industry has a lot to do with the booming life sciences sector, growing incidence of chronic ailments, and increasing investment by corporations for emerging advanced and efficient therapeutic agents.
In the recent past, pipettes held the largest share, of more than 21%, in the liquid handling system market, and this trend will continue in the future. It is because of the increase in count of pipette calibration service providers and the introduction of cutting-edge pipettes. For example, in May 2022, Eppendorf Corporate opened the SPLASH in Chennai. The dispenser category has a considerable share in the recent past, because of the introduction of cutting-edge dispensing systems. Sartorius’s rLINE robotic liquid handling dispenser is one of the advanced products. It offers precise and dependable sample processing with its DC motor, electronic braking system, conductive robotic tips, optical sensor, and liquid level sensor.
Liquid handling systems are mostly used for making drug discoveries, this is the reason why this category had a key share. Over 20,000 drugs under development will be launched in the near future. Liquid handling systems are important in every stage of the drug discovery procedure. Furthermore, corporations are emphasizing on capacity developments for discovering drugs. Clinical diagnostics had the second-largest share, chiefly as a result of the growing incidence of chronic ailments. Liquid handling systems are extensively used at diagnostic centers and even the diagnostic labs at hospitals.
North America was the leading region in the liquid handling system market in the recent past, with a share, of about 36%, because of the growing count of mergers & acquisitions amongst biotech companies. Furthermore, the rising pharma and biotech industries are having a positive influence on the growth of the industry. Furthermore, corporations are investing in the consumer healthcare business for developing effective therapies.
The U.S. will produce a substantial revenue by 2030 in the region, rising at a rate of about 4.5% in the years to come. This has a lot to do with the presence of a many major healthcare device and pharma companies and the surge in the requirement for the appropriate management and steadying of pharma and biotech production procedures.
The booming life sciences industry, and the growing prevalence of chronic diseases all over the world, the demand for liquid handling systems is on the rise. And, what’s more, this trend will continue in the years to come as well.
SOURCE: P&S Intelligence
Comments